Endogenous lithium deficiency—driven by amyloid sequestration—accelerates Alzheimer's pathology by activating GSK3β kinase, triggering neuroinflammation, synapse loss, and cognitive decline in mouse models. Researchers demonstrate that lithium orotate, which evades amyloid binding, prevents disease progression and restores memory, suggesting a new therapeutic avenue grounded in disrupted metal homeostasis.